Alpha 2.0
Login Register
» Authors » Yuichiro Endo

Yuichiro Endo

Explore the profile of Yuichiro Endo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 155
Followers 0
Related Specialties
Dermatology
General Medicine
Biomedical Engineering
Top 10 Co-Authors
Kenji Kabashima
Yoshiki Miyachi
Miki Tanioka
Akihiro Fujisawa
Yo Kaku
Atsushi Otsuka
Hideaki Tanizaki
Teruki Dainichi
Takashi Nomura
Atsushi Utani
Published In
Eur J Dermatol
J Dermatol
Case Rep Dermatol Med
Case Rep Dermatol
Acta Derm Venereol
Affiliations
Soon will be listed here.
Recent Articles
1.
Elevation of serum carcinoembryonic antigen as a possible predictor of response to pulse methylprednisolone in acquired idiopathic generalized anhidrosis
Sakiyama T, Endo Y, Nakamizo S, Kabashima K
Clin Exp Dermatol . 2024 Aug; 50(1):125-129. PMID: 39215567
Background: Acquired idiopathic generalized anhidrosis (AIGA) is a rare disorder primarily observed in Asian populations, particularly in Japan. Although pulse methylprednisolone therapy is an effective treatment for AIGA, predictors of...
2.
Lymphedema-associated angiosarcoma uniquely localized on the left thigh and anterior abdominal wall secondary to central obesity and multiple surgeries
Hirano-Lotman Y, Kogame T, Kaku Y, Komatsu-Fujii T, Endo Y, Nomura T, et al.
J Dermatol . 2023 Oct; 51(3):e83-e85. PMID: 37830441
No abstract available.
3.
Cutaneous Adnexal Adenocarcinoma: Genomic Analysis and Successful HER2-targeted Therapy of Metastatic Disease
Hirano-Lotman Y, Ishida Y, Endo Y, Ogawa S, Kabashima K
Acta Derm Venereol . 2023 Aug; 103:adv9399. PMID: 37584093
No abstract available.
4.
Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy
Yonekura S, Endo Y, Fujii H, Ishikawa M, Egawa G, Kabashima K
J Dermatol . 2023 Jul; 50(11):1493-1496. PMID: 37400887
Cutaneous angiosarcoma (CAS) is a rare soft-tissue sarcoma of vascular endothelial origin. Paclitaxel (PTX) and docetaxel (DTX) are used as systemic chemotherapy; however, chemoresistance often occurs in CAS. Switching one...
5.
Necrotizing fasciitis with slow progression in a patient with rheumatoid arthritis receiving tocilizumab
Goto K, Kogame T, Kusuba N, Endo Y, Dainichi T, Kabashima K
Eur J Dermatol . 2022 Jul; 32(2):279-280. PMID: 35866917
No abstract available.
6.
Metabolic syndrome and comorbidities in patients with psoriasis: a community-based case-control study from the Nagahama cohort in Japan
Endo Y, Tabara Y, Kawaguchi T, Onoufriadis A, McGrath J, Matsuda F, et al.
Eur J Dermatol . 2022 May; 32(1):86-93. PMID: 35514103
No abstract available.
7.
Clinical practice guidelines for pseudoxanthoma elasticum (2017): Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee
Iwanaga A, Utani A, Koike Y, Okubo Y, Kuwatsuka Y, Endo Y, et al.
J Dermatol . 2022 Jan; 49(3):e91-e98. PMID: 35019155
Pseudoxanthoma elasticum (PXE) is a progressive hereditary disease that affects tissues such as the skin, retina, blood vessels, and gastrointestinal tracts. Therefore, comprehensive medical care across clinical departments specialized in...
8.
Extensive leg ulcer caused by primary cutaneous cryptococcosis in an immunocompromised patient
Inoue N, Endo Y, Kabashima K
Eur J Dermatol . 2021 Nov; 31(5):657-658. PMID: 34726158
No abstract available.
9.
Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations
Oiwa T, Ishibashi M, Okuno T, Ohba M, Endo Y, Uozumi R, et al.
J Dermatol . 2021 Jun; 48(9):1442-1446. PMID: 34114674
Pachydermoperiostosis (PDP) is a genetic disease characterized by digital clubbing, periostosis, and pachydermia caused by mutated HPGD or SLCO2A1. Plasma prostaglandin (PG)E levels are increased in these patients. However, other...
10.
Benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma on the leg
Sakaguchi Y, Komori T, Kaku Y, Fujimoto M, Endo Y, Kabashima K
J Dermatol . 2021 May; 48(8):e372-e373. PMID: 33942353
No abstract available.